AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimify-M1 Tablet

Prescription Icon
Prescription Required

Marketer

Fidus Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimify-M1 Tablet

DiaBeta-Duo tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. DiaBeta-Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse reaction is hypoglycemia (low blood sugar). Learn to recognize symptoms—sweating, dizziness, headache, trembling—and know how to treat them. Maintain regular meals and carry a fast-acting glucose source, such as candy or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is possible. DiaBeta-Duo is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before starting treatment. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Glimify-M1 Tablet

Managing type 2 diabetes

Major Benefits of Glimify-M1 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimify-M1 Tablet with a meal.

Common Side effects of Glimify-M1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimify-M1 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimify-M1 Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

How Glimify-M1 Tablet works:

Glimify-M1 tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimify-M1 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimify-M1 Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimify-M1 tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimify-M1 Tablets to individuals with kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Glimify-M1 Tablets are contraindicated in patients exhibiting severe kidney dysfunction. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimify-M1 Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe liver disease.

What if you forget to take Glimify-M1 Tablet :

Should you forget a Glimify-M1 Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Glimify-M1 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimify-M1 Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimify-M1 Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimify-M1 Tablet and seek immediate medical attention.
Glimify-M1 Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimify-M1 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimify-M1 Tablet use can lead to Vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental Vitamin B12 is recommended at least annually by some researchers.
Glimify-M1 Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimify-M1 tablets and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Glimify-M1 Tablet
41
MRP 50
18% off